PROKIDNEY CORP. 8-K

What Happened
ProKidney Corp. announced an updated investor presentation in a Form 8‑K filed on January 12, 2026 under Item 7.01 (Regulation FD Disclosure). The company said senior management intends to use the Presentation when interacting with investors and analysts. The presentation is posted on ProKidney’s investor site (https://investors.prokidney.com/news-events/events-and-presentations) and is attached to the filing as Exhibit 99.1. The 8‑K was signed by Todd Girolamo, Chief Legal Officer.

Key Details

• Filing: Form 8‑K filed January 12, 2026 (Item 7.01, Regulation FD Disclosure).
• Presentation: Updated investor presentation posted on ProKidney’s investor website and attached as Exhibit 99.1.
• Use: Management intends to use the Presentation in investor and analyst interactions.
• Signature: Report signed by Todd Girolamo, Chief Legal Officer.

Why It Matters
This disclosure makes ProKidney’s current investor materials and messaging broadly available under Regulation FD, so investors and analysts can review the same slides management will use in public and private outreach. The filing itself does not report financial results, executive changes, or other material corporate actions — it simply provides updated presentation material that may include the company’s latest program status, milestones or strategic outlook. Investors should review the posted Presentation for any updated facts or timelines relevant to their evaluation.